<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95116">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01866618</url>
  </required_header>
  <id_info>
    <org_study_id>RMA-2013-01</org_study_id>
    <nct_id>NCT01866618</nct_id>
  </id_info>
  <brief_title>Natural Cycle In Vitro Fertilization</brief_title>
  <official_title>Natural Cycle In Vitro Fertilization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reproductive Medicine Associates of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reproductive Medicine Associates of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Natural IVF study patients will undergo an IVF cycle with trigger shots of Lupron &amp; hCG.
      Patients will not be given any other stimulating medications during the cycle. They will
      have 2 uterine aspirations and an endometrial biopsy at designated times. The first uterine
      aspiration will be randomized to one of four days (day before retrieval, day of retrieval,
      day after retrieval or 2 days after retrieval). The second uterine aspiration and
      endometrial biopsy will be performed 6 days after retrieval. Any embryo(s) obtained will be
      biopsied for Comprehensive Chromosome Screening (CCS) and frozen for use in a subsequent
      thaw cycle.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endometrial Changes</measure>
    <time_frame>1 Year</time_frame>
    <description>To examine the endometrium within the natural cycle in order to accurately characterize the differences in multiple aspects of endocrine and paracrine hormonal activity, the transcriptome of cells influencing oocyte maturation and changes in the endometrium.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aneuploidy Rates</measure>
    <time_frame>1 Year</time_frame>
    <description>To examine aneuploidy rates in embryos from natural IVF cycles.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Temporal Embryonic Development</measure>
    <time_frame>1 Year</time_frame>
    <description>To examine the parameters of temporal embryonic development and the transcriptome of granulosa cells and follicular fluid. The embryos will be graded at standard time points to determine whether there are differences in in vitro development. Granulosa cells and follicular fluid will undergo gene expression analysis and compared to the gene expression profiles found in those specimens in stimulated cycles.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">524</enrollment>
  <condition>Natural Cycle in Vitro Fertilization (IVF)</condition>
  <arm_group>
    <arm_group_label>Natural IVF Cycle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will undergo a natural IVF cycle using trigger shots of Leuprolide Acetate(Lupron) and human chorionic gonadotropin (hCG) to ensure the patient surges.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Uterine Aspiration and Endometrial Biopsy/Embryo Biopsy</intervention_name>
    <description>Patients will undergo two uterine aspirations and one endometrial biopsy. Any embryos obtained will undergo embryo biopsy for Comprehensive Chromosome Screening (CCS). All embryos will be cryopreserved for subsequent use in a thaw cycle.</description>
    <arm_group_label>Natural IVF Cycle</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Leuprolide Acetate</intervention_name>
    <arm_group_label>Natural IVF Cycle</arm_group_label>
    <other_name>Lupron 40U (2 mgs)given subcutaneously twice at 12 hour intervals to induce ovulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Human Chorionic Gonadotropin (hCG)</intervention_name>
    <arm_group_label>Natural IVF Cycle</arm_group_label>
    <other_name>hCG 10,000U given subcutaneously once to induce ovulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ovulatory cycles every 39 days or less (natural cycle IVF cannot be performed in
             someone who does not have cycles)

          -  Must be RMANJ patient and have completed all diagnostic screening at one of our RMANJ
             locations. All diagnostic screening is NOT covered under the study and must be
             completed prior to being allowed to start the study cycle.

        Exclusion Criteria:

          -  Prior enrollment/attempt in this study

          -  Requirement for surgical sperm extraction

          -  Inability to assess ovaries via transvaginal ultrasound

          -  Inability to tolerate vaginal examination
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard T Scott, M.D., HCLD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Reproductive Medicine Associates of New Jersey</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Reproductive Medicine Associates of New Jersey</name>
      <address>
        <city>Basking Ridge</city>
        <state>New Jersey</state>
        <zip>07920</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.rmanj.com</url>
    <description>Reproductive Medicine Associates of New Jersey</description>
  </link>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 16, 2017</lastchanged_date>
  <firstreceived_date>May 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Natural</keyword>
  <keyword>IVF Cycle</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Leuprolide</mesh_term>
    <mesh_term>Chorionic Gonadotropin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
